Literature DB >> 9473214

Shortened telomeres involved in a case with a jumping translocation at 1q21.

S Hatakeyama1, K Fujita, H Mori, M Omine, F Ishikawa.   

Abstract

The jumping translocation (JT) is a rare chromosomal abnormality in which a specific chromosomal segment translocates onto the ends of various chromosomes (jumps). In most cases, the region distal to 1q21 jumps onto numerous different telomeres. Here we report a molecular study of the JT involving 1q21 found in a patient with acute myelomonocytic leukemia that had transformed from myelodysplastic syndrome (MDS). This is the first report describing the analysis of the molecular structure of the JT. We demonstrated the presence of a stretch of telomeric repeats at the breakpoint by means of a fluorescence in situ hybridization experiment, molecular cloning, and nucleotide sequencing of the fused region. A significant amount of variant telomeric repeats (a telomeric sequence having one-base mismatch within the authentic telomeric repeat TTAGGG) was found in this region. The variant telomeric repeat has been shown to be present in the proximal region of telomeres and does not perform telomeric functions by itself. Therefore, these results indicated that the telomeres had already been critically shortened when the jumps occurred. We suggest that the extended proliferation of cancer cells during the premalignant stage, such as MDS, results in chromosomal instability due to the loss of telomeric functions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9473214

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Jumping Translocations in Myeloid Malignancies Associated With Treatment Resistance and Poor Survival.

Authors:  David Sanford; Courtney D DiNardo; Guilin Tang; Jorge E Cortes; Srdan Verstovsek; Elias Jabbour; Farhad Ravandi; Hagop Kantarjian; Guillermo Garcia-Manero
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2015-06-06

2.  Partners in crime: Tbf1 and Vid22 promote expansions of long human telomeric repeats at an interstitial chromosome position in yeast.

Authors:  Elina A Radchenko; Anna Y Aksenova; Kirill V Volkov; Alexander A Shishkin; Youri I Pavlov; Sergei M Mirkin
Journal:  PNAS Nexus       Date:  2022-06-08

3.  Jumping translocations in myelodysplastic syndromes.

Authors:  Cecilia C S Yeung; H Joachim Deeg; Colin Pritchard; David Wu; Min Fang
Journal:  Cancer Genet       Date:  2016-08-08

4.  Jumping translocation in acute monocytic leukemia (M5b) with alternative breakpoint sites in the long arm of donor chromosome 3.

Authors:  Peter McGrattan; Amy Logan; Mervyn Humphreys; Margaret Bowers
Journal:  Med Oncol       Date:  2009-07-22       Impact factor: 3.064

5.  Unbalanced jumping translocation involving 3q in myeloproliferative disease.

Authors:  Peter McGrattan; Mervyn Humphreys; Donald Hull
Journal:  Med Oncol       Date:  2008-05-29       Impact factor: 3.064

6.  A Newborn with Genital Ambiguity, 45,X/46,XY Mosaicism, a Jumping Chromosome Y, and Congenital Adrenal Hyperplasia.

Authors:  Lei Zhang; Linda D Cooley; Sonal R Chandratre; Atif Ahmed; Jill D Jacobson
Journal:  Case Rep Endocrinol       Date:  2013-10-22

Review 7.  At the Beginning of the End and in the Middle of the Beginning: Structure and Maintenance of Telomeric DNA Repeats and Interstitial Telomeric Sequences.

Authors:  Anna Y Aksenova; Sergei M Mirkin
Journal:  Genes (Basel)       Date:  2019-02-05       Impact factor: 4.096

8.  Jumping Translocations of 1q in Myelodysplastic Syndrome and Acute Myeloid Leukemia: Report of Three Cases and Review of Literature.

Authors:  T Couture; K Amato; A DiAdamo; P Li
Journal:  Case Rep Genet       Date:  2018-09-09

9.  Jumping translocations of chromosome 1q occurring by a multi-stage process in an acute myeloid leukemia progressed from myelodysplastic syndrome with a TET2 mutation.

Authors:  Ina Lee; Mary A Gudipati; Elizabeth Waters; Vu H Duong; Maria R Baer; Ying Zou
Journal:  Mol Cytogenet       Date:  2019-11-19       Impact factor: 2.009

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.